Home/Filings/4/0000899243-22-023977
4//SEC Filing

Weis Holger 4

Accession 0000899243-22-023977

CIK 0001107421other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 4:30 PM ET

Size

15.6 KB

Accession

0000899243-22-023977

Insider Transaction Report

Form 4
Period: 2022-06-22
Weis Holger
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2022-06-22+40,000160,167 total
  • Award

    Employee Stock Option (right to buy)

    2022-06-22+100,000100,000 total
    Exercise: $0.82Exp: 2032-06-21Common Stock (100,000 underlying)
Holdings
  • Common Stock

    (indirect: By Children)
    1,240
  • Common Stock

    (indirect: By Spouse)
    19,000
  • Common Stock

    (indirect: By Children)
    1,000
  • Common Stock

    (indirect: By Children)
    200
Footnotes (2)
  • [F1]Includes 30,000 shares held in a joint account by the Reporting Person and his spouse.
  • [F2]The option vests in twelve equal monthly installments beginning on July 13, 2022.

Issuer

Alaunos Therapeutics, Inc.

CIK 0001107421

Entity typeother

Related Parties

1
  • filerCIK 0001846984

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:30 PM ET
Size
15.6 KB